Health News

New RA Drugs May Reduce Hospital Stays
Patients with rheumatoid arthritis are admitted to hospitals for a number of reasons. They may need surgery, or the inflammation caused by their disease may lead to health problems in other organs.
RA Drugs May Prevent Early Death
Rheumatoid arthritis not only affects your joints, but also other organs throughout the body. When other organs are affected, patients may be faced with serious problems, even death. One type of drug may lower this risk.
RA Patients Did Well with Specialty Help
Controlling the pain and swelling of rheumatoid arthritis is no easy task. As such, treating the disease requires a specialist. A recent study suggests that patients should see a specialist as soon as possible.
Different Drugs, Same Death Rates
When it comes to treating rheumatoid arthritis, there are a number of drugs that can be used. Each drug works differently and has different risks. Do these differences also mean different death rates?
AS Medication Didn't Change Heart Risks
A long term disease named  Ankylosing   Spondylitis has been linked to a higher risk of cardiovascular problems. A number of factors could be responsible for this increased risk, including the drugs used to treat this painful condition.
To Switch or Not To Switch AS Drugs
No two patients with ankylosing spondylitis are exactly the same. As such, a drug treatment that works for one patient may not work for the other. When one drug isn't working out, patients may turn to another drug.
Doses Cut, PsA Remission Remains
In many patients, medication can effectively treat psoriatic arthritis. But it is not always wise to keep patients on the same drug dose for too long. After lowering dose, does drug treatment still keep disease at bay?
RA Drugs Carry Similar Risk
Many experts recommend that rheumatoid arthritis patients get early drug treatment to slow down their disease and prevent disability. With so many drug options, it's important to know the safety of each drug.
Humira Approved in Europe for Treatment of Spondyloarthritis
Abbott announced that the European Commission (EC) has approved Humira (adalimumab) for the treatment of adults with severe axial spondyloarthritis (axSpA) who have no X-ray evidence of structural damage.
Humira Works for Spondyloarthritis
Non-steroidal anti-inflammatory drugs ( NSAIDs ) are used often to treat axial spondyloarthritis - a type of spinal arthritis. When these drugs don't work, doctors and patients have to find another option.